Stockreport

Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day

Sutro Biopharma, Inc.  (STRO) 
Last sutro biopharma, inc. earnings: 11/8 07:00 am Check Earnings Report
PDF - Company has initiated Phase 1 study with STRO-004, its potential best-in-class Tissue Factor ADC -  - Sutro has selected PTK7 as the target for its initial dual-paylo [Read more]